Fisher & Paykel Healthcare to announce Full Year Results on 23 May 2014

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it intends to release on Friday, 23 May 2014 its financial results for the year ended 31 March 2014. The release will be issued shortly after 9:00am NZST, 7:00am AEST (5:00pm USEDT, Thursday, 22 May).

Fisher & Paykel Healthcare will host a conference call on Friday, 23 May 2014 to review the results and to discuss the outlook for the 2015 financial year. The conference call is scheduled to begin at 10:00am NZST, 8:00am AEST (6:00pm USEDT, Thursday, 22 May) and will be broadcast simultaneously over the Internet.

To listen to the webcast, access the company’s website at Please allow extra time prior to the webcast to visit the site and download the streaming media software if required. An online archive of the event will be available approximately two hours after the webcast and will remain on the site for two weeks.

To attend the conference call, participants will need to dial in to one of the numbers below at least 5 minutes prior to the scheduled call time and identify yourself to the operator. When prompted, please quote the conference code of: 40710638.
New Zealand Toll Free 0800 446 046 USA Toll Free 1800 742 9301
Australia Toll Free 1800 725 000 Hong Kong Toll Free 800 906 648
United Kingdom Toll Free 0808 234 1369 International +61 2 8373 3610

An audio replay of the conference call will be available approximately 2 hours after the call and will be accessible for two weeks by dialing one of the numbers below. When prompted please enter the conference code of: 40710638

New Zealand Toll Free 0800 453 213 USA Toll Free 1855 452 5696
Australia Toll Free 1800 153 898 Hong Kong Toll Free 800 963 117
United Kingdom Toll Free 0808 234 0072 International +61 2 9003 4211
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website
Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.